Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001157523-09-003985
Filing Date
2009-05-18
Accepted
2009-05-18 15:00:23
Documents
5
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 OPEXA THERAPEUTICS, INC. 10-K/A a5965440.htm 10-K/A 130143
2 EXHIBIT 23.1 a5965440ex23_1.htm EX-23.1 2916
3 EXHIBIT 31.1 a5965440ex31_1.htm EX-31.1 23484
4 EXHIBIT 32.1 a5965440ex32_1.htm EX-32.1 11607
5 LOGO opxalogo.jpg GRAPHIC 1521
  Complete submission text file 0001157523-09-003985.txt   172100
Mailing Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381
Business Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

EIN.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33004 | Film No.: 09836482
SIC: 2834 Pharmaceutical Preparations